Annual Cash & Cash Equivalents
$104.75 M
+$694.00 K+0.67%
December 31, 2021
Summary
- As of February 10, 2025, SRRA annual cash & cash equivalents is $104.75 million, with the most recent change of +$694.00 thousand (+0.67%) on December 31, 2021.
- During the last 3 years, SRRA annual cash & cash equivalents has fallen by -$1.30 million (-1.22%).
Performance
SRRA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$274.01 M
+$169.27 M+161.59%
March 31, 2022
Summary
- As of February 10, 2025, SRRA quarterly cash and cash equivalents is $274.01 million, with the most recent change of +$169.27 million (+161.59%) on March 31, 2022.
- Over the past year, SRRA quarterly cash and cash equivalents has increased by +$166.36 million (+154.52%).
Performance
SRRA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SRRA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.7% | +154.5% |
| 3 y3 years | -1.2% | +201.4% |
| 5 y5 years | +4.4% | +119.2% |
SRRA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -61.8% |
| 5 y | 5-year | -29.0% | -0.7% | at high | -66.9% |
| alltime | all time | -30.3% | -97.7% | at high | -94.2% |
Sierra Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $274.01 M(+161.6%) |
| Dec 2021 | $104.75 M(+0.7%) | $104.75 M(+7.9%) |
| Sep 2021 | - | $97.07 M(+7.0%) |
| Jun 2021 | - | $90.69 M(-15.8%) |
| Mar 2021 | - | $107.66 M(+3.5%) |
| Dec 2020 | $104.06 M(-29.5%) | $104.06 M(-4.5%) |
| Sep 2020 | - | $109.01 M(-11.5%) |
| Jun 2020 | - | $123.23 M(-7.7%) |
| Mar 2020 | - | $133.53 M(-9.5%) |
| Dec 2019 | $147.53 M(+39.1%) | $147.53 M(+117.9%) |
| Sep 2019 | - | $67.69 M(-14.1%) |
| Jun 2019 | - | $78.83 M(-13.3%) |
| Mar 2019 | - | $90.91 M(-14.3%) |
| Dec 2018 | $106.05 M | $106.05 M(-8.7%) |
| Sep 2018 | - | $116.13 M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $125.42 M(-6.3%) |
| Mar 2018 | - | $133.83 M(+33.4%) |
| Dec 2017 | $100.35 M(-7.9%) | $100.35 M(-6.9%) |
| Sep 2017 | - | $107.82 M(-7.6%) |
| Jun 2017 | - | $116.70 M(-6.7%) |
| Mar 2017 | - | $125.03 M(+14.7%) |
| Dec 2016 | $109.01 M(-27.4%) | $109.01 M(-11.1%) |
| Sep 2016 | - | $122.68 M(-6.0%) |
| Jun 2016 | - | $130.55 M(-7.3%) |
| Mar 2016 | - | $140.87 M(-6.2%) |
| Dec 2015 | $150.18 M(+415.1%) | $150.18 M(-4.5%) |
| Sep 2015 | - | $157.31 M(+895.6%) |
| Jun 2015 | - | $15.80 M(-34.3%) |
| Mar 2015 | - | $24.05 M(-17.5%) |
| Dec 2014 | $29.15 M(+1100.2%) | $29.15 M |
| Dec 2013 | $2.43 M | - |
FAQ
- What is Sierra Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sierra Oncology?
- What is Sierra Oncology annual cash & cash equivalents year-on-year change?
- What is Sierra Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sierra Oncology?
- What is Sierra Oncology quarterly cash and cash equivalents year-on-year change?
What is Sierra Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of SRRA is $104.75 M
What is the all time high annual cash & cash equivalents for Sierra Oncology?
Sierra Oncology all-time high annual cash & cash equivalents is $150.18 M
What is Sierra Oncology annual cash & cash equivalents year-on-year change?
Over the past year, SRRA annual cash & cash equivalents has changed by +$694.00 K (+0.67%)
What is Sierra Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SRRA is $274.01 M
What is the all time high quarterly cash and cash equivalents for Sierra Oncology?
Sierra Oncology all-time high quarterly cash and cash equivalents is $274.01 M
What is Sierra Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, SRRA quarterly cash and cash equivalents has changed by +$166.36 M (+154.52%)